• Latest
  • Trending
Von Hippel-Lindau Disease (VHL)

Von Hippel-Lindau Disease (VHL)

July 30, 2024

NEET PG Free Tests

December 30, 2025
The Ultimate FMGE Final 7 Days Strategy (2025): A Data-Driven Blueprint for Guaranteed Success

The Ultimate FMGE Final 7 Days Strategy (2025): A Data-Driven Blueprint for Guaranteed Success

December 13, 2025
Ultra-High-Yield One Liners

Ultra-High-Yield One Liners

December 13, 2025
FMGE 2025 High-Yield Clinical Vignettes: One-Line Diagnosis & Immediate Management

FMGE 2025 High-Yield Clinical Vignettes: One-Line Diagnosis & Immediate Management

December 13, 2025
FMGE 2025 Last-Minute Flowcharts & Tables You Must Memorize

FMGE 2025 Last-Minute Flowcharts & Tables You Must Memorize

December 13, 2025
fmge-7-days-study-plan

FMGE 2025: What to Read in the Last 7 Days & Final 48 Hours

December 13, 2025
Important Questions For FMGE Series

Important Questions For FMGE Series

December 13, 2025
FMGE December 2017 Full Recall Part 1

FMGE December 2017 Full Recall Part 1

December 13, 2025
FMGE June 2018 Full Recall Part 1

FMGE June 2018 Full Recall Part 1

December 13, 2025
FMGE Dec 2018 Full Recall Part 1

FMGE Dec 2018 Full Recall Part 1

December 13, 2025
FMGE RECALL JUNE 2019

FMGE RECALL JUNE 2019

December 13, 2025
FMGE RECALL DEC – 2019

FMGE RECALL DEC – 2019

December 13, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Sunday, February 1, 2026
DMA Edu
  • Home
  • About
    • TEAM
    • FACULTIES
    • PARTNERS
  • Exams
    • INDIA
      • FMGE
      • NEET-UG
      • NEET PG
      • NExT
    • ABROAD
      • PLAB
      • USMLE
      • SMLE
      • DHA
  • Courses
  • Products
    • FMGE APP
    • NEET-PG APP
    • USMLE APP
    • DHA APP
  • FREEBIES
    • RESOURCES
    • TESTS
    • APPS
      • FMGE APP
      • NEET-PG APP
      • USMLE APP
      • DHA APP
  • Daily
No Result
View All Result
DMA Edu
No Result
View All Result
Home RAT series

Von Hippel-Lindau Disease (VHL)

by Dr.P.Harinath
July 30, 2024
in RAT series
246 10
0
498
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

Points to Ponder for NEET-PG, FMGE & NEXT

  • VHL is an autosomal dominant disorder caused by mutations in the VHL tumor suppressor gene.
  • The main clinical features are hemangioblastomas (cerebellum, spine, retina), renal cysts and clear cell RCC, and pheochromocytomas.
  • Regular screening with abdominal ultrasound, brain MRI, urinary VMA, and ophthalmoscopy is essential for early detection and management.

Genetic Basis:

  • Autosomal dominant inheritance.
  • Mutation in the VHL gene located on chromosome 3.
  • The VHL gene codes for the VHL tumor suppressor protein, which regulates cell growth and angiogenesis (blood vessel formation).

Clinical Manifestations:

  • Can involve various organ systems due to benign (hemangioblastomas) and malignant (carcinomas) tumors.
  • Hemangioblastomas: Benign, slow-growing tumors with many blood vessels. Can occur in various locations:
    • Cerebellum (most common site)
    • Spinal cord
    • Retina (causing vision problems)
  • Renal cysts and clear cell renal cell carcinoma (RCC):
    • Multiple renal cysts are frequent.
    • Increased risk of developing bilateral (both kidneys) clear cell RCC, a malignant kidney cancer.
  • Pheochromocytomas: Tumors of the adrenal glands that produce catecholamines (hormones) and can cause high blood pressure, headaches, sweating, and palpitations.

Screening and Surveillance:

Early detection and management are crucial due to the potential for malignancy (RCC) and complications from other tumors. A regular screening protocol is recommended:

  • Annual abdominal ultrasound: To monitor for renal cysts and RCC development.
  • Baseline brain MRI at 20 years old and annual neurological examination: To detect hemangioblastomas in the brain and spinal cord.
  • Annual measurement of urinary metanephrines (VMA): To screen for pheochromocytomas.
  • Annual ophthalmoscopy: To check for retinal hemangioblastomas.

Management:

  • Treatment depends on the location, size, and symptoms of the tumors.
  • Options include surgery, radiation therapy, targeted medications (e.g., mTOR inhibitors for RCC), and watchful waiting.
  • Genetic counseling is recommended for affected individuals and family members.

Quiz

Von Hippel-Lindau Disease (VHL)

Page 1 of 2
True about VHL syndrome is
Page 2 of 2
Von Hippel Lindau is associated with all except,
Dr.P.Harinath

Dr.P.Harinath

DMA Edu

Copyright © 2017 DMAedu.

Navigate Site

  • About
  • Advertise
  • Privacy & Policy
  • Contact

Follow Us

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • About
    • TEAM
    • FACULTIES
    • PARTNERS
  • Exams
    • INDIA
      • FMGE
      • NEET-UG
      • NEET PG
      • NExT
    • ABROAD
      • PLAB
      • USMLE
      • SMLE
      • DHA
  • Courses
  • Products
    • FMGE APP
    • NEET-PG APP
    • USMLE APP
    • DHA APP
  • FREEBIES
    • RESOURCES
    • TESTS
    • APPS
      • FMGE APP
      • NEET-PG APP
      • USMLE APP
      • DHA APP
  • Daily

Copyright © 2017 DMAedu.